# OXYBUTYNIN CHLORIDE
> **ANDA209823** · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2017-10-23
## Drug
- **FDA Application Number:** ANDA209823
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXYBUTYNIN CHLORIDE
- **Generic name:** OXYBUTYNIN CHLORIDE
- **Active ingredients:** OXYBUTYNIN CHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVITIUM PHARMA
- **Manufacturer:** ANI Pharmaceuticals, Inc.
- **First approval:** 2017-10-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209823)
---
*MORVS · CC0 1.0*